Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: a study protocol for an Expanded Access Programme

View ORCID ProfileJosephine Bourner, Festus Devincy Redji Mbrenga, View ORCID ProfileChristian Noël Malaka, Jake Dunning, Amanda Rojek, Emmanuel Fandema, Peter Horby, Yap Boum II, Emmanuel Nakouné, View ORCID ProfilePiero Olliaro
doi: https://doi.org/10.1101/2022.11.28.22282846
Josephine Bourner
1Pandemic Sciences Institute, University of Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Josephine Bourner
  • For correspondence: josephine.bourner@ndm.ox.ac.uk
Festus Devincy Redji Mbrenga
2Institut Pasteur de Bangui, Central African Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Noël Malaka
2Institut Pasteur de Bangui, Central African Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christian Noël Malaka
Jake Dunning
1Pandemic Sciences Institute, University of Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Rojek
1Pandemic Sciences Institute, University of Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmanuel Fandema
3Ministry of Health, Central African Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Horby
1Pandemic Sciences Institute, University of Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yap Boum II
2Institut Pasteur de Bangui, Central African Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmanuel Nakouné
2Institut Pasteur de Bangui, Central African Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Piero Olliaro
1Pandemic Sciences Institute, University of Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Piero Olliaro
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Monkeypox is a viral zoonotic disease commonly reported in humans in parts of Central and West Africa. This protocol is for an Expanded Access Programme (EAP) to be implemented in the Central African Republic, where Clade I monkeypox virus diseases is primarily responsible for most monkeypox infections. The objective of the programme is to provide patients with confirmed monkeypox with access to tecovirimat, a novel antiviral targeting orthopoxviruses, and collect data on clinical and virological outcomes of patients to inform future research.

Methods The study will be conducted at participating hospitals in the Central African Republic. All patients who provide informed consent to enrol in the programme will receive tecovirimat. Patients will remain in hospital for the duration of treatment. Data on clinical signs and symptoms will be collected every day while the patient is hospitalised. Blood, throat and lesion samples will be collected at baseline and then on days 4, 8, 14 and 28. Patient outcomes will be assessed on Day 14 – end of treatment – and at Day 28. Adverse event and serious adverse event data will be collected from the point of consent until Day 28.

Discussion This EAP is the first protocolised treatment programme in Clade I MPXV. The data generated under this protocol aims to describe the use of tecovirimat for Clade I disease in a monkeypox endemic region of Central Africa. It is hoped that this data can inform the definition of outcome measures used in future research and contribute to the academic literature around the use of tecovirimat for the treatment of monkeypox. The EAP also aims to bolster research capacity in the region in order for robust randomised controlled trials to take place for monkeypox and other diseases.

Trial registration {2a & 2b}ISRCTN43307947

View this table:
  • View inline
  • View popup

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ISRCTN43307947

Funding Statement

The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Not Applicable

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This Expanded Access Programme was approved by the University of Oxford Tropical Research Ethics Committee (ref: 1-20) and the University of Bangui Scientific Research Ethics Committee.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Not Applicable

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Not Applicable

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Not Applicable

Data Availability

No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.

  • ABBREVIATIONS

    CAR
    Central African Republic
    Co-I
    Co-Investigator
    CRF
    Case Report Form
    D
    Programme day
    IB
    Investigator’s Brochure
    IMP
    Investigational Medicinal Product
    NTD
    Neglected Tropical Disease
    PI
    Principal Investigator
    PIS
    Patient Information Sheet
    RCT
    Randomised Controlled Trial
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
    Back to top
    PreviousNext
    Posted November 29, 2022.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: a study protocol for an Expanded Access Programme
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: a study protocol for an Expanded Access Programme
    Josephine Bourner, Festus Devincy Redji Mbrenga, Christian Noël Malaka, Jake Dunning, Amanda Rojek, Emmanuel Fandema, Peter Horby, Yap Boum II, Emmanuel Nakouné, Piero Olliaro
    medRxiv 2022.11.28.22282846; doi: https://doi.org/10.1101/2022.11.28.22282846
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: a study protocol for an Expanded Access Programme
    Josephine Bourner, Festus Devincy Redji Mbrenga, Christian Noël Malaka, Jake Dunning, Amanda Rojek, Emmanuel Fandema, Peter Horby, Yap Boum II, Emmanuel Nakouné, Piero Olliaro
    medRxiv 2022.11.28.22282846; doi: https://doi.org/10.1101/2022.11.28.22282846

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (227)
    • Allergy and Immunology (501)
    • Anesthesia (110)
    • Cardiovascular Medicine (1233)
    • Dentistry and Oral Medicine (206)
    • Dermatology (147)
    • Emergency Medicine (282)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (529)
    • Epidemiology (10012)
    • Forensic Medicine (5)
    • Gastroenterology (498)
    • Genetic and Genomic Medicine (2448)
    • Geriatric Medicine (236)
    • Health Economics (479)
    • Health Informatics (1636)
    • Health Policy (751)
    • Health Systems and Quality Improvement (635)
    • Hematology (248)
    • HIV/AIDS (532)
    • Infectious Diseases (except HIV/AIDS) (11860)
    • Intensive Care and Critical Care Medicine (625)
    • Medical Education (252)
    • Medical Ethics (74)
    • Nephrology (268)
    • Neurology (2277)
    • Nursing (139)
    • Nutrition (350)
    • Obstetrics and Gynecology (452)
    • Occupational and Environmental Health (534)
    • Oncology (1245)
    • Ophthalmology (375)
    • Orthopedics (133)
    • Otolaryngology (226)
    • Pain Medicine (155)
    • Palliative Medicine (50)
    • Pathology (324)
    • Pediatrics (729)
    • Pharmacology and Therapeutics (311)
    • Primary Care Research (282)
    • Psychiatry and Clinical Psychology (2280)
    • Public and Global Health (4828)
    • Radiology and Imaging (834)
    • Rehabilitation Medicine and Physical Therapy (490)
    • Respiratory Medicine (650)
    • Rheumatology (283)
    • Sexual and Reproductive Health (237)
    • Sports Medicine (226)
    • Surgery (266)
    • Toxicology (44)
    • Transplantation (125)
    • Urology (99)